Atlas Trials

An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes

Clinical trial NCT06959030 · RECRUITING

Trial details

NCT number
NCT06959030
Sponsor
Second Affiliated Hospital of Guangxi Medical University
Status
RECRUITING
Study type
OBSERVATIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2025-06-19
Primary completion
2026-09-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.